RankAlpha logo
Back to Rankings

ACTU

Actuate TherapeuticsN/A
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
ACTU vs peer average
50/100
ACTU vs. peer average (N/A vs. D)
Grade spread
B 2 · C 1 · D 1 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

KALA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $44.43M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerKALAKALA BIO
ACTU
Actuate Therapeutics
KALA
KALA BIO
Grade
N/A
D
Momentum
30
39
Value
-
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Unrated
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs KALA

ACTU / KALA
Grade Position
In line
ACTU vs. peer average (N/A vs. D)
50/100
Momentum
30
KALA
Value
-
-
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ACTU
1
KALA
KALA BIO Inc Common
D
40/100
-
2
ELUT
Elutia Inc Class A Common
F
20/100
-
3
MIRA
MIRA Pharmaceuticals Inc Common
F
20/100
-
4
ESLA
Estrella Immunopharma Inc Common
F
20/100
-
5
RKTO
Rocket One Inc Common
F
20/100
-
KALA is the first peer returned for this comparison set.